Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1177 to 1226 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 1177\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent golgi complex associated protein 1; golgi resident protein gcp60; peripherial benzodiazepine receptor associated protein; golgi phosphoprotein 1; pbr associated protein; pka (rialpha)-associated protein. [source:refseq;acc:nm\_022735]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 218.186\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 212.672\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.02593\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1178\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent delta-sarcoglycan (sg-delta) (35 kda dystrophin-associated glycoprotein) (35dag). [source:swissprot;acc:q92629]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1179\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cellular modulator of immune recognition. [source:refseq;acc:nm\_145021]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1180\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent vacuolar atp synthase 21 kda proteolipid subunit (ec 3.6.3.14) (hatpl). [source:swissprot;acc:q99437]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1181\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-sarcoglycan (gamma-sg) (35 kda dystrophin-associated glycoprotein) (35dag). [source:swissprot;acc:q13326]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1182\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent neurocalcin delta. [source:swissprot;acc:p29554]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 225.104\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 230.931\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02589\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1183\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent neuron specific calcium-binding protein hippocalcin (p23k) (calcium- binding protein bdr-2). [source:swissprot;acc:p32076]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 225.103\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 230.928\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02588\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1184\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent arf gtpase-activating protein git1 (g protein-coupled receptor kinase- interactor 1). [source:swissprot;acc:q9y2x7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 216.729\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 222.334\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02586\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1185\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent visinin-like protein 3 (vilip-3) (calcium-binding protein bdr-1) (hlp2) (hippocalcin-like protein 1). [source:swissprot;acc:p37235]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 225.094\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 230.913\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02585\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1186\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent adp-ribosylation factor-like protein 7 (adp-ribosylation factor-like protein lak). [source:swissprot;acc:p56559]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 218.402\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 212.904\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.02582\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1187\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent vacuolar atp synthase subunit d (ec 3.6.3.14) (v-atpase d subunit) (vacuolar proton pump d subunit) (v-atpase ac39 subunit) (v-atpase 40 kda accessory protein) (p39) (32 kda accessory protein). [source:swissprot;acc:p12953]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1188\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent adp-ribosylation factor-like protein 4. [source:swissprot;acc:p40617]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1189\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent alpha-1-acid glycoprotein 2 precursor (agp 2) (orosomucoid 2) (omd 2). [source:swissprot;acc:p19652]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 209.649\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 204.406\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02565\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1190\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin. [source:swissprot;acc:p02248]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 209.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 204.372\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.02558\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1191\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent upstream binding protein 1 (lbp-1a). [source:refseq;acc:nm\_014517]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 220.742\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 215.237\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1192\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transcription factor cp2; transcription factor cp2, alpha globin. [source:refseq;acc:nm\_005653]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1193\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lbp-9. [source:refseq;acc:nm\_014553]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1194\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent splicing factor, arginine/serine-rich 3 (pre-mrna splicing factor srp20) (x16 protein). [source:swissprot;acc:p23152]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1195\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent skeletal muscle lim-protein 3 (slim 3) (lim-domain protein dral) (four and a half lim domains protein 2) (fhl-2). [source:swissprot;acc:q14192]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 269.608\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 276.493\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02554\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1196\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent kinesin protein. [source:refseq;acc:nm\_032559]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 224.858\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 219.264\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02551\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1197\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mstp028 protein. [source:refseq;acc:nm\_031954]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 219.042\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02548\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1198\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent skeletal muscle lim-protein 2 (slim 2) (four and a half lim domains protein 3) (fhl-3). [source:swissprot;acc:q13643]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 269.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 276.454\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02546\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1199\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent u3 small nucleolar ribonucleoprotein protein mpp10 (m phase phosphoprotein 10). [source:swissprot;acc:o00566]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 241.496\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 235.508\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02543\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1200\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent swi/snf related, matrix associated, actin dependent regulator of chromatin subfamily b member 1 (integrase interactor 1 protein) (hsnf5) (baf47). [source:swissprot;acc:q12824]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 219.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.604\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.0254\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1201\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial precursor (ec 1.3.5.1) (fp) (flavoprotein subunit of complex ii). [source:swissprot;acc:p31040]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 210.986\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 216.344\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1202\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent diphthamide biosynthesis-like protein 2. [source:refseq;acc:nm\_001384]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 227.274\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 233.041\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02537\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1203\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tumor necrosis factor, alpha-induced protein 1, endothelial (b12 protein). [source:swissprot;acc:q13829]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 219.023\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.606\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02536\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1204\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent polymerase delta-interacting protein 1; tnfaip1-like. [source:refseq;acc:nm\_178863]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 219.022\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.607\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02535\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1205\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ny-ren-62 antigen (fragment). [source:sptrembl;acc:q9y590]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 224.805\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 219.251\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02533\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1206\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent integral membrane protein cii-3b. [source:sptrembl;acc:o75609]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 207.646\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.891\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02526\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1207\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent succinate dehydrogenase cytochrome b560 subunit, mitochondrial precursor (integral membrane protein cii-3) (qps1) (qps-1) (succinate dehydrogenase complex subunit c) (succinate-ubiquinone oxidoreductase cytochrome b large subunit) (cybl). [source:swissprot;acc:q99643]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 207.644\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.888\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02525\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1208\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent signal recognition particle receptor alpha subunit (sr-alpha) (docking protein alpha) (dp-alpha). [source:swissprot;acc:p08240]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 224.878\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 219.342\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02524\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1209\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent succinate dehydrogenase [ubiquinone] iron-sulfur protein, mitochondrial precursor (ec 1.3.5.1) (ip) (iron-sulfur subunit of complex ii). [source:swissprot;acc:p21912]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 207.931\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.175\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02522\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1210\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent kinesin-like protein kif2 (kinesin-2) (hk2). [source:swissprot;acc:o00139]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 224.764\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 219.241\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02519\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1211\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent chromosome 11 open reading frame2; chromosome 11 open reading frame2. [source:refseq;acc:nm\_013265]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 214.364\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 219.759\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.02517\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1212\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent kinesin-like protein kif13a (kinesin-like protein rbkin). [source:swissprot;acc:q9h1h9]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1213\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent conserved oligomeric golgi complex component 2 (low density lipoprotein receptor defect c-complementing protein). [source:swissprot;acc:q14746]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1214\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent kinesin-like protein kif13b (kinesin-like protein gakin). [source:swissprot;acc:q9nqt8]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1215\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent daz associated protein 1 isoform b; deleted in azoospermia associated protein 1. [source:refseq;acc:nm\_018959]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.268\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.916\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02514\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1216\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent retinoic acid induced 17; pias-like protein hzimp10. [source:refseq;acc:nm\_020338]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.269\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.918\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02513\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1217\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent glutaminyl-trna synthase (glutamine-hydrolyzing)-like 1. [source:refseq;acc:nm\_018292]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 211.959\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 217.258\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.025\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1218\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent fatty-acid amide hydrolase (ec 3.1.-.-) (oleamide hydrolase) (anandamide amidohydrolase). [source:swissprot;acc:o00519]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1219\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent coactosin-like protein. [source:swissprot;acc:q14019]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1220\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent uracil-dna glycosylase, mitochondrial precursor (ec 3.2.2.-) (udg). [source:swissprot;acc:p13051]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1221\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent probable glutamyl-trna(gln) amidotransferase subunit b, mitochondrial precursor (ec 6.3.5.-) (glu-adt subunit b) (cytochrome oxidase assembly factor pet112 homolog). [source:swissprot;acc:o75879]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1222\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tumor protein d53 (hd53) (d52-like 1). [source:swissprot;acc:q16890]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 206.774\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 211.936\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02496\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1223\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tumor protein d52 (n8 protein). [source:swissprot;acc:p55327]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 206.771\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 211.926\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02493\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1224\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent folylpolyglutamate synthase, mitochondrial precursor (ec 6.3.2.17) (folylpoly-gamma-glutamate synthetase) (fpgs). [source:swissprot;acc:q05932]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 225.906\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 231.524\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02487\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1225\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin-conjugating enzyme e2 e1 (ec 6.3.2.19) (ubiquitin-protein ligase e1) (ubiquitin carrier protein e1) (ubch6). [source:swissprot;acc:p51965]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 166.846\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 170.989\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.02483\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1226\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin-conjugating enzyme e2e 3; ubiquitin carrier protein; ubiquitin-protein ligase. [source:refseq;acc:nm\_006357]\vspace{3pt}}&&&\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/